Related references
Note: Only part of the references are listed.NLRP3 inflammasome in traumatic brain injury: Its implication in the disease pathophysiology and potential as a therapeutic target
Rohan Chakraborty et al.
LIFE SCIENCES (2023)
Blood glutamate scavenging as a novel glutamate-based therapeutic approach for post-traumatic brain injury anxiety and social impairment
Dmitry Frank et al.
TRANSLATIONAL PSYCHIATRY (2023)
α7 Nicotinic acetylcholine receptor: a key receptor in the cholinergic anti-inflammatory pathway exerting an antidepressant effect
Huiyang Liu et al.
JOURNAL OF NEUROINFLAMMATION (2023)
Emotion Dysregulation Following Trauma: Shared Neurocircuitry of Traumatic Brain Injury and Trauma-Related Psychiatric Disorders
Carissa N. Weis et al.
BIOLOGICAL PSYCHIATRY (2022)
The Kynurenine Pathway in Traumatic Brain Injury: Implications for Psychiatric Outcomes
Timothy B. Meier et al.
BIOLOGICAL PSYCHIATRY (2022)
Cognitive Impairment in Primary and Secondary Headache Disorders
Olivia Begasse de Dhaem et al.
CURRENT PAIN AND HEADACHE REPORTS (2022)
Association between microglial activation and serum kynurenine pathway metabolites in multiple sclerosis patients
Maija Saraste et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2022)
Blast-related traumatic brain injury is mediated by the kynurenine pathway
Yu Zhang et al.
NEUROREPORT (2022)
Positive association between serum quinolinic acid and functional connectivity following concussion
Timothy B. Meier et al.
BRAIN BEHAVIOR AND IMMUNITY (2021)
DAMPs and RAGE Pathophysiology at the Acute Phase of Brain Injury: An Overview
Baptiste Balanca et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Indoleamine and tryptophan 2,3-dioxygenases as important future therapeutic targets
Ana Dolsak et al.
PHARMACOLOGY & THERAPEUTICS (2021)
Ketamine's effect on inflammation and kynurenine pathway in depression: A systematic review
Emma Kopra et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2021)
Long term neuroprotective effects of acute single dose MK-801treatment against traumatic brain injury in immature rats
Ayse Cigel et al.
NEUROPEPTIDES (2021)
Prospective study of the effects of sport-related concussion on serum kynurenine pathway metabolites
Timothy B. Meier et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Cerebrospinal Fluid Neurofilament Light Chain Is Associated with Kynurenine Pathway Metabolite Changes in Multiple Sclerosis
Cecilia Rajda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The Gut Microbiota, Kynurenine Pathway, and Immune System Interaction in the Development of Brain Cancer
Mona Dehhaghi et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Cellular infiltration in traumatic brain injury
Aftab Alam et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Systematic Review on the Involvement of the Kynurenine Pathway in Stroke: Pre-clinical and Clinical Evidence
Gabriela D. Colpo et al.
FRONTIERS IN NEUROLOGY (2019)
Microorganisms, Tryptophan Metabolism, and Kynurenine Pathway: A Complex Interconnected Loop Influencing Human Health Status
Mona Dehhaghi et al.
INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH (2019)
IDO and TDO as a potential therapeutic target in different types of depression
Yanjie Qin et al.
METABOLIC BRAIN DISEASE (2018)
Centers for Disease Control and Prevention Guideline on the Diagnosis and Management of Mild Traumatic Brain Injury Among Children
Angela Lumba-Brown et al.
JAMA PEDIATRICS (2018)
Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research
Andrew I. R. Maas et al.
LANCET NEUROLOGY (2017)
The far-reaching scope of neuroinflammation after traumatic brain injury
Dennis W. Simon et al.
NATURE REVIEWS NEUROLOGY (2017)
Involvement of the kynurenine pathway in the pathogenesis of Parkinson's disease
Chai K. Lim et al.
PROGRESS IN NEUROBIOLOGY (2017)
Abnormalities in Kynurenine Pathway Metabolism in Treatment-Resistant Depression and Suicidality: A Systematic Review
Gianluca Serafini et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2017)
Mood symptoms correlate with kynurenine pathway metabolites following sports-related concussion
Rashmi Singh et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder
Timothy B. Meier et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral Ischemia
Maria Isabel Cuartero et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation
L. Brundin et al.
TRANSLATIONAL PSYCHIATRY (2016)
Neurotoxic kynurenine metabolism is increased in the dorsal hippocampus and drives distinct depressive behaviors during inflammation
J. M. Parrott et al.
TRANSLATIONAL PSYCHIATRY (2016)
Traumatic brain injuries
Kaj Blennow et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans
Edwin B. Yan et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Expression of the Kynurenine Pathway in Human Peripheral Blood Mononuclear Cells: Implications for Inflammatory and Neurodegenerative Disease
Simon P. Jones et al.
PLOS ONE (2015)
Reduction of Brain Kynurenic Acid Improves Cognitive Function
Rouba Kozak et al.
JOURNAL OF NEUROSCIENCE (2014)
Kynurenic acid as an antagonist of α7 nicotinic acetylcholine receptors in the brain: Facts and challenges
Edson X. Albuquerque et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Kynurenic acid, by targeting 7 nicotinic acetylcholine receptors, modulates extracellular GABA levels in the rat striatum in vivo
Sarah Beggiato et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2013)
Quinolinic Acid: An Endogenous Neurotoxin with Multiple Targets
Rafael Lugo-Huitron et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
Quinolinic acid, the inescapable neurotoxin
Gilles J. Guillemin
FEBS JOURNAL (2012)
Kynurenines in the mammalian brain: when physiology meets pathology
Robert Schwarcz et al.
NATURE REVIEWS NEUROSCIENCE (2012)
Kynurenine Pathway in Schizophrenia: Pathophysiological and Therapeutic Aspects
Norbert Mueller et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission?
Johann Steiner et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Kynurenine and its metabolites in Alzheimer's disease patients
E. Gulaj et al.
ADVANCES IN MEDICAL SCIENCES (2010)
In Situ Detection of Inflammatory Mediators in Post Mortem Human Brain Tissue after Traumatic Injury
Tony Frugier et al.
JOURNAL OF NEUROTRAUMA (2010)
Involvement of Pro- and Anti-Inflammatory Cytokines and Chemokines in the Pathophysiology of Traumatic Brain Injury
Jenna M. Ziebell et al.
NEUROTHERAPEUTICS (2010)
The Kynurenine Pathway and Inflammation in Amyotrophic Lateral Sclerosis
Yiquan Chen et al.
NEUROTOXICITY RESEARCH (2010)
Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease
Ka Ka Ting et al.
JOURNAL OF NEUROINFLAMMATION (2009)
Pathophysiology of Traumatic Brain Injury
Mark W. Greve et al.
MOUNT SINAI JOURNAL OF MEDICINE (2009)
Mechanism for Quinolinic Acid Cytotoxicity in Human Astrocytes and Neurons
Nady Braidy et al.
NEUROTOXICITY RESEARCH (2009)
Moderate and severe traumatic brain injury in adults
Andrew I. R. Maas et al.
LANCET NEUROLOGY (2008)
From inflammation to sickness and depression: when the immune system subjugates the brain
Robert Dantzer et al.
NATURE REVIEWS NEUROSCIENCE (2008)
The involvement of astrocytes and kynurenine pathway in Alzheimer's disease
Ka Ka Ting et al.
NEUROTOXICITY RESEARCH (2007)
Pathophysiology of traumatic brain injury
C. Werner et al.
BRITISH JOURNAL OF ANAESTHESIA (2007)
Kynurenine pathway in major depression:: Evidence of impaired neuroprotection
Aye-Mu Myint et al.
JOURNAL OF AFFECTIVE DISORDERS (2007)
The effect of the selective NMDA receptor antagonist traxprodil in the treatment of traumatic brain injury
L Yurkewicz et al.
JOURNAL OF NEUROTRAUMA (2005)
Effects of the dopaminergic agent and NMDA receptor antagonist amantadine on cognitive function, cerebral glucose metabolism and D2 receptor availability in chronic traumatic brain injury: A study using positron emission tomography (PET)
MF Kraus et al.
BRAIN INJURY (2005)
ATP mediates rapid microglial response to local brain injury in vivo
D Davalos et al.
NATURE NEUROSCIENCE (2005)
Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex
Gilles J. Guillemin et al.
JOURNAL OF NEUROINFLAMMATION (2005)
Involvement of quinolinic acid in AIDS dementia complex
GJ Guillemin et al.
NEUROTOXICITY RESEARCH (2005)
Prognosis for mild traumatic brain injury:: Results of the WHO Collaborating Centre Task Force on Mild Traumatic Brain Injury
LJ Carroll et al.
JOURNAL OF REHABILITATION MEDICINE (2004)
Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes
RG Tavares et al.
NEUROCHEMISTRY INTERNATIONAL (2002)
Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease
GJ Guillemin et al.
REDOX REPORT (2002)
Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection
GJ Guillemin et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)